| Literature DB >> 28935634 |
Yan Chen1,2, Ju-Hua Liu1,3, Zhe Zhen1, Yuan Zuo1, Qingshan Lin4, Mingya Liu2, Chunting Zhao2, Min Wu2, Gaozhen Cao2, Run Wang2, Hung-Fat Tse1,2,5, Kai-Hang Yiu1,2,5.
Abstract
A non-dipper pattern of high blood pressure is associated with increased risk of organ damage and cardiovascular disease in patients with hypertension. The aim of the study was to evaluate the left ventricular (LV) remodeling and function and arterial stiffness in a dipper/non-dipper pattern of high blood pressure in patients with hypertension. A total of 183 hypertensive patients with no history of adverse cardiovascular events were divided into two groups based on 24 hours ambulatory blood pressure monitoring (ABPM): 66 patients with a dipper pattern and 117 patients with non-dipper pattern. Detailed transthoracic echocardiogram was performed and analyzed with advance speckle tracking 3-orthogonal direction strain analysis to assess LV systolic function and tissue Doppler-derived E/E' for LV diastolic function assessment. Cardio ankle vascular index (CAVI) was used to evaluate arterial stiffness. Compared with patients with dipper hypertension, those with non-dipper hypertension had increased LV mass index, higher prevalence of eccentric and concentric LV hypertrophy, more impaired LV diastolic and systolic function and peripheral arterial stiffness. Multivariable analysis revealed that a non-dipper pattern was independently associated with LV systolic dysfunction evaluated by speckle tracking-derived strain analysis. In conclusion, a non-dipper pattern of hypertension is an independent risk factor for LV systolic dysfunction. Treatment that could reverse this non-dipper pattern may reduce cardiac damage in these patients. © American Federation for Medical Research (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: arterial stiffness; cardiac function; non-dipper hypertension; speckle tracking strain
Mesh:
Year: 2017 PMID: 28935634 PMCID: PMC5800354 DOI: 10.1136/jim-2017-000513
Source DB: PubMed Journal: J Investig Med ISSN: 1081-5589 Impact factor: 2.895
Clinical data for dipper and non-dipper hypertensive patients
| Variables | Total (n=183) | Dipper (n=66) | Non-dipper (n=117) | p Value |
| Demographic data | ||||
| Age, years | 46.5±12.6 | 44.6±11.3 | 47.5±13.2 | 0.131 |
| Male, n (%) | 106 (57.9) | 42 (63.6) | 64 (54.7) | 0.240 |
| Body mass index, kg/m2 | 26.1±4.1 | 25.6±3.9 | 26.4±4.2 | 0.174 |
| Body surface area, m2 | 1.79±0.21 | 1.79±0.19 | 1.79±0.23 | 0.862 |
| Medical history | ||||
| Hypertension duration, years | 5.0±5.7 | 4.1±4.9 | 5.3±5.8 | 0.201 |
| Diabetes mellitus, n (%) | 22 (12.0) | 7 (10.6) | 15 (12.8) | 0.658 |
| Hyperlipidemia, n (%) | 63 (34.4) | 25 (37.9) | 38 (32.5) | 0.460 |
| Current smoker, n (%) | 31 (16.9) | 13 (19.7) | 18 (15.4) | 0.455 |
| Medication | ||||
| ACEI/ARB, n (%) | 67 (36.6) | 17 (25.8) | 50 (42.7) | 0.022 |
| CCB, n (%) | 138 (75.4) | 51 (77.3) | 87 (74.4) | 0.660 |
| Beta-blocker, n (%) | 42 (23.0) | 10 (15.2) | 32 (27.4) | 0.060 |
| Diuretic, n (%) | 30 (16.4) | 14 (21.2) | 16 (13.7) | 0.186 |
| Clinical data | ||||
| Office SBP, mm Hg | 152.7±25.6 | 154.4±29.4 | 151.8±23.3 | 0.520 |
| Office DBP, mm Hg | 93.5±17.6 | 95.6±19.6 | 92.3±16.4 | 0.226 |
| Daytime SBP, mm Hg | 138.5±15.2 | 139.8±15.1 | 137.8±15.3 | 0.381 |
| Daytime DBP, mm Hg | 87.2±12.9 | 89.2±12.9 | 86.1±12.8 | 0.117 |
| Night-time SBP, mm Hg | 129.3±14.9 | 121.8±12.2 | 133.5±14.7 | <0.001 |
| Night-time DBP, mm Hg | 80.9±12.0 | 76.7±11.1 | 83.1±11.9 | <0.001 |
| 24 hours mean SBP, mm Hg | 134.3±14.1 | 131.2±13.1 | 136.1±14.3 | 0.026 |
| 24 hours mean DBP, mm Hg | 84.6±12.0 | 83.4±11.9 | 85.2±12.0 | 0.349 |
| Daytime MAP, mm Hg | 104.3±12.7 | 106.1±12.5 | 103.3±12.7 | 0.154 |
| Night-time MAP, mm Hg | 97.0±11.9 | 91.7±10.5 | 99.9±11.7 | <0.001 |
| 24 hours mean heart rate, bpm | 75.0±9.7 | 75.1±11.0 | 75.0±8.9 | 0.890 |
| Blood chemistry | ||||
| HbA1c, % | 5.8±1.0 | 5.8±1.0 | 5.7±1.0 | 0.699 |
| TG, mmol/L | 1.7±0.9 | 1.7±0.9 | 1.8±0.9 | 0.507 |
| TC, mmol/L | 4.7±1.1 | 4.7±1.1 | 4.8±1.1 | 0.667 |
| HDL, mmol/L | 1.2±0.3 | 1.2±0.3 | 1.2±0.4 | 0.759 |
| LDL, mmol/L | 3.1±0.9 | 3.1±1.0 | 3.0±0.9 | 0.605 |
| Creatinine, mmol/L | 74.1±19.7 | 76.4±20.4 | 72.8±19.2 | 0.278 |
Except where otherwise indicated, values are the mean±SD or n (%).
ACEI, ACE converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MAP, mean artery pressure; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
Comparison of LV function and arterial stiffness between dipper and non-dipper hypertensive patients
| Variables | Total (n=183) | Dipper (n=66) | Non-dipper (n=117) | p Value |
| IVSD, cm | 1.05±0.16 | 1.03±0.16 | 1.06±0.16 | 0.149 |
| LVDD, cm | 4.74±0.52 | 4.73±0.52 | 4.75±0.52 | 0.775 |
| LVPWD, cm | 1.00±0.15 | 0.96±0.12 | 1.01±0.16 | 0.018 |
| RWT | 0.42±0.07 | 0.41±0.06 | 0.43±0.07 | 0.034 |
| LVMI, g/m2 | 98.1±26.8 | 92.3±22.3 | 101.3±28.6 | 0.029 |
| LV geometry | ||||
| Normal, n (%) | 63 (34.4) | 32 (48.5) | 31 (26.5) | 0.001 |
| Concentric remodeling, n (%) | 57 (31.1) | 23 (34.8) | 34 (29.1) | |
| Eccentric LVH, n (%) | 32 (17.5) | 6 (9.1) | 26 (22.2) | |
| Concentric LVH, n (%) | 31 (16.9) | 5 (7.6) | 26 (22.2) | |
| LVEDV, mL | 83.4±22.7 | 81.2±20.9 | 84.6±23.6 | 0.332 |
| LVESV, mL | 30.9±11.6 | 29.8±11.8 | 31.5±11.4 | 0.328 |
| LVEF, % | 63.8±5.2 | 64.4±5.0 | 63.4±5.3 | 0.180 |
| E/A ratio | 1.00±0.29 | 1.03±0.28 | 0.99±0.30 | 0.357 |
| E/E′ ratio | 8.24±2.28 | 7.62±2.03 | 8.58±2.35 | 0.006 |
| LS, % | −18.7±3.1 | −19.6±3.1 | −18.2±3.0 | 0.003 |
| CS, % | −18.6±3.5 | −19.9±3.5 | −17.8±3.3 | <0.001 |
| RS, % | 32.4±9.3 | 36.6±10.0 | 29.8±7.9 | <0.001 |
| CAVI, m/s | 8.12±1.32 | 7.83±1.08 | 8.29±1.43 | 0.025 |
Except where otherwise indicated, values are the mean±SD or n (%).
A, peak velocity of mitral inflow in early diastole; CAVI, cardio ankle vascular index; CS, circumferential strain; E, peak velocity of mitral inflow in late diastole; E/A ratio, ratio of peak velocity of mitral inflow in early and late diastole; E/E′, ratio of early diastolic mitral velocity to mean peak early diastolic velocity at septal and lateral annulus; E′, mean peak early diastolic velocity at septal and lateral annulus; IVSD, interventricular septum thickness at end-diastole; LS, longitudinal strain; LV, left ventricular; LVDD, left ventricular dimension at end-diastole; LVEDV, LV end-diastolic volume; LVEF, LV ejection fraction; LVESV, LV end-systolic volume; LVH, LV hypertrophy; LVMI, LV mass index; LVPWD, LV posterior wall thickness at end-diastole; RS, radial strain; RWT, relative wall thickness.
Evaluation of the independent association of non-dipper hypertension with cardiovascular abnormalities
| Variables | Myocardial involvement | Atrial stiffness | ||||||||
| LS | CS | RS | E/E′-mean | CAVI | ||||||
| B (95% CI) | p Value | B (95% CI) | p Value | B (95% CI) | p Value | B (95% CI) | p Value | B (95% CI) | p Value | |
| Non-dipper/dipper hypertension | ||||||||||
| Unadjusted | 1.39 (0.49 to 2.29) | 0.003 | 2.08 (1.02 to 3.14) | <0.001 | −6.77 (−9.52 to −4.02) | <0.001 | 0.96 (0.28 to 1.64) | 0.006 | 0.46 (0.06 to 0.86) | 0.025 |
| *Adjusted | 1.04 (0.12 to 1.96) | 0.028 | 1.90 (0.73 to 3.07) | 0.002 | −6.52 (−9.51 to −3.53) | <0.001 | 0.55 (−0.07 to 1.16) | 0.079 | 0.24 (−0.12 to 0.60) | 0.196 |
*Adjusted for age, gender, body mass index, 24 hours mean SBP and DBP, hypertension duration, diabetes mellitus, hyperlipidemia, current smoker, ARB or ACEI, CCB, beta-blocker, diuretics, resistant hypertension.
B, unstandardized regression coefficient; CAVI, cardio ankle vascular index; CS, circumferential strain; E/E′, ratio of early diastolic mitral velocity to mean peak early diastolic velocity at septal and lateral annulus; LS, longitudinal strain; RS, radial strain.